data_1qsz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qsz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.615 ' OG ' HG23 ' A' ' 131' ' ' THR . 40.2 t . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.386 0.136 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.37 -36.34 75.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.404 0.681 . . . . 0.0 111.334 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.615 HG23 ' OG ' ' A' ' 129' ' ' SER . 11.9 t -82.91 -47.37 11.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.694 1.197 . . . . 0.0 110.996 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.88 -80.78 0.51 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -157.74 126.43 2.98 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.5 -42.81 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.966 2.444 . . . . 0.0 111.333 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -67.65 133.46 49.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.907 0.883 . . . . 0.0 111.548 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.67 -52.48 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -106.52 124.99 50.43 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.74 1.216 . . . . 0.0 108.468 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttt -157.39 147.37 20.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 109.055 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -168.78 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.527 1.131 . . . . 0.0 112.011 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 t -122.92 -65.18 1.12 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.064 0.946 . . . . 0.0 108.729 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.57 -53.27 0.72 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.939 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.65 121.03 83.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.51 142.95 69.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.441 2.76 . . . . 0.0 112.275 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.59 117.96 11.0 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.85 97.17 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -89.76 113.25 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -78.79 92.34 4.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.5 ptm -95.89 179.84 4.96 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.311 1.044 . . . . 0.0 111.896 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.6 m -150.06 135.81 18.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.722 1.609 . . . . 0.0 107.328 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.93 163.1 20.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 110.548 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.82 -49.69 4.06 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -89.07 179.61 6.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.333 1.053 . . . . 0.0 110.755 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -72.98 141.9 47.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.249 0.619 . . . . 0.0 111.032 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.7 tp -132.76 114.16 13.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.834 1.654 . . . . 0.0 107.599 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.0 t -98.8 133.25 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.04 97.35 15.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.63 82.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.409 2.739 . . . . 0.0 111.33 -167.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.5 p -127.7 50.63 2.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.032 1.333 . . . . 0.0 109.286 175.168 65.026 -164.392 -76.336 103.742 2.047 103.166 -160.865 -55.244 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.9 ptt180 -70.04 158.22 36.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.244 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.14 168.64 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.315 1.446 . . . . 0.0 110.027 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.2 p -66.11 -26.24 67.37 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.81 0.844 . . . . 0.0 112.983 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.0 m -156.23 146.07 15.56 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.134 0.879 . . . . 0.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.56 -31.6 60.09 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.802 3.001 . . . . 0.0 112.121 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -50.4 -35.25 27.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.423 1.489 . . . . 0.0 112.065 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.36 -41.67 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 110.738 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.5 m 66.46 94.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.467 1.507 . . . . 0.0 111.524 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.48 145.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.2 m -111.86 125.68 54.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.428 1.091 . . . . 0.0 108.121 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.7 tp -89.39 100.7 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -91.45 172.38 8.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.89 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -149.36 146.44 27.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.319 1.048 . . . . 0.0 108.444 171.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.92 135.14 83.56 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 110.662 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.6 -58.93 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.728 0 CA-C-N 119.814 0.969 . . . . 0.0 111.839 0.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.85 39.66 1.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.787 1.235 . . . . 0.0 109.631 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -80.56 156.45 26.47 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -127.16 113.23 16.1 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.122 0.969 . . . . 0.0 109.163 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 mp -89.86 82.65 6.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.17 129.18 88.39 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.089 0.955 . . . . 0.0 109.292 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.56 84.42 1.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.089 2.526 . . . . 0.0 109.917 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.52 -21.01 61.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.311 1.444 . . . . 0.0 113.367 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.57 29.07 62.19 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.436 0.541 . . . . 0.0 112.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.63 -62.45 0.52 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.829 1.252 . . . . 0.0 108.297 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -87.46 -60.86 1.86 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 36.1 mt -89.67 93.23 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.1 mt -96.72 119.22 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 108.121 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -89.13 96.88 10.9 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.219 0.607 . . . . 0.0 109.6 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -92.36 101.02 13.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.703 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 76.9 p -54.15 -31.42 52.44 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.634 0.774 . . . . 0.0 113.07 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -100.72 19.64 16.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.365 1.066 . . . . 0.0 112.336 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -147.58 -55.13 0.22 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.846 0.748 . . . . 0.0 111.298 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.46 -170.55 35.75 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -88.93 107.67 19.14 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 52.7 mt -89.88 94.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.598 1.559 . . . . 0.0 107.961 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.48 94.5 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.5 p -58.33 -39.79 80.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.773 1.229 . . . . 0.0 112.484 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -118.46 96.81 5.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.739 1.215 . . . . 0.0 107.98 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.59 142.94 55.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.217 0.607 . . . . 0.0 110.45 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 57.0 p -138.76 178.7 6.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.097 0.959 . . . . 0.0 109.519 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -53.0 -30.2 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.026 1.33 . . . . 0.0 112.118 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.47 -23.01 56.62 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.623 1.169 . . . . 0.0 111.97 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -113.94 37.85 3.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.32 1.048 . . . . 0.0 111.147 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 56.2 mt -114.94 102.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 155.21 -161.89 30.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.97 91.6 8.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.617 0.767 . . . . 0.0 109.458 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.48 155.36 33.88 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 22.6 m -147.89 111.46 5.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 59.4 m -77.13 130.87 37.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 170.595 -55.244 -160.865 -76.336 103.166 2.047 103.742 -164.392 65.026 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -131.64 142.44 49.85 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.171 0.989 . . . . 0.0 110.233 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.69 106.61 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.254 1.022 . . . . 0.0 109.368 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.5 m -89.85 87.32 6.91 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.52 -93.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.953 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.42 64.89 8.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.677 0.671 . . . . 0.0 109.377 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.42 41.45 63.34 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.405 1.002 . . . . 0.0 112.056 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -150.08 117.29 6.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.59 99.3 1.27 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.331 0.653 . . . . 0.0 109.696 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -89.65 133.73 34.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -150.59 162.81 39.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.997 0.362 . . . . 0.0 111.905 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.2 t -153.54 139.52 18.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.845 0.858 . . . . 0.0 109.87 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -108.45 145.29 34.87 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.084 1.354 . . . . 0.0 112.123 -169.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.94 106.93 4.68 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.237 1.415 . . . . 0.0 108.685 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.6 tt -87.35 108.45 18.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.1 p -89.53 93.31 9.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.161 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.65 117.78 28.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 108.546 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.44 128.94 37.89 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -77.73 65.98 3.32 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 55.1 p -0.47 -88.27 0.0 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 130.022 3.329 . . . . 0.0 114.872 -169.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.41 82.78 6.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.547 1.139 . . . . 0.0 109.006 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.1 m -76.66 74.79 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.694 0.798 . . . . 0.0 109.947 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 1.081 ' OXT' HD12 ' A' ' 229' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.733 -1.603 . . . . 0.0 110.921 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.573 ' OG ' HG22 ' A' ' 131' ' ' THR . 40.2 t . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.386 0.136 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.37 -36.34 75.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.404 0.681 . . . . 0.0 111.334 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.573 HG22 ' OG ' ' A' ' 129' ' ' SER . 11.9 t -82.91 -47.37 11.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.694 1.197 . . . . 0.0 110.996 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.88 -80.78 0.51 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -157.74 126.43 2.98 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.5 -42.81 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.966 2.444 . . . . 0.0 111.333 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -67.65 133.46 49.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.907 0.883 . . . . 0.0 111.548 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.67 -52.48 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -106.52 124.99 50.43 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.74 1.216 . . . . 0.0 108.468 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttt -157.39 147.37 20.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 109.055 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -168.78 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.527 1.131 . . . . 0.0 112.011 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 t -122.92 -65.18 1.12 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.064 0.946 . . . . 0.0 108.729 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.57 -53.27 0.72 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.939 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.65 121.03 83.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.51 142.95 69.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.441 2.76 . . . . 0.0 112.275 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.59 117.96 11.0 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.85 97.17 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -89.76 113.25 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -78.79 92.34 4.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.5 ptm -95.89 179.84 4.96 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.311 1.044 . . . . 0.0 111.896 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.6 m -150.06 135.81 18.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.722 1.609 . . . . 0.0 107.328 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.93 163.1 20.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 110.548 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.82 -49.69 4.06 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -89.07 179.61 6.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.333 1.053 . . . . 0.0 110.755 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -72.98 141.9 47.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.249 0.619 . . . . 0.0 111.032 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.7 tp -132.76 114.16 13.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.834 1.654 . . . . 0.0 107.599 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.0 t -98.8 133.25 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.04 97.35 15.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.63 82.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.409 2.739 . . . . 0.0 111.33 -167.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.5 p -127.7 50.63 2.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.032 1.333 . . . . 0.0 109.286 175.168 65.026 -164.392 -76.336 103.742 2.047 103.166 -160.865 -55.244 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.9 ptt180 -70.04 158.22 36.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.244 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.14 168.64 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.315 1.446 . . . . 0.0 110.027 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.2 p -66.11 -26.24 67.37 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.81 0.844 . . . . 0.0 112.983 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.0 m -156.23 146.07 15.56 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.134 0.879 . . . . 0.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.56 -31.6 60.09 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.802 3.001 . . . . 0.0 112.121 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -50.4 -35.25 27.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.423 1.489 . . . . 0.0 112.065 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.36 -41.67 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 110.738 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.5 m 66.46 94.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.467 1.507 . . . . 0.0 111.524 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.48 145.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.2 m -111.86 125.68 54.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.428 1.091 . . . . 0.0 108.121 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.7 tp -89.39 100.7 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -91.45 172.38 8.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.89 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -149.36 146.44 27.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.319 1.048 . . . . 0.0 108.444 171.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.92 135.14 83.56 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 110.662 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.6 -58.93 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.728 0 CA-C-N 119.814 0.969 . . . . 0.0 111.839 0.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.85 39.66 1.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.787 1.235 . . . . 0.0 109.631 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -80.56 156.45 26.47 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -127.16 113.23 16.1 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.122 0.969 . . . . 0.0 109.163 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 mp -89.86 82.65 6.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.17 129.18 88.39 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.089 0.955 . . . . 0.0 109.292 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.56 84.42 1.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.089 2.526 . . . . 0.0 109.917 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.52 -21.01 61.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.311 1.444 . . . . 0.0 113.367 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.57 29.07 62.19 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.436 0.541 . . . . 0.0 112.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.63 -62.45 0.52 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.829 1.252 . . . . 0.0 108.297 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -87.46 -60.86 1.86 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 36.1 mt -89.67 93.23 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.1 mt -96.72 119.22 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 108.121 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -89.13 96.88 10.9 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.219 0.607 . . . . 0.0 109.6 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -92.36 101.02 13.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.703 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 76.9 p -54.15 -31.42 52.44 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.634 0.774 . . . . 0.0 113.07 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -100.72 19.64 16.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.365 1.066 . . . . 0.0 112.336 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -147.58 -55.13 0.22 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.846 0.748 . . . . 0.0 111.298 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.46 -170.55 35.75 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -88.93 107.67 19.14 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 52.7 mt -89.88 94.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.598 1.559 . . . . 0.0 107.961 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.48 94.5 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.5 p -58.33 -39.79 80.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.773 1.229 . . . . 0.0 112.484 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -118.46 96.81 5.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.739 1.215 . . . . 0.0 107.98 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.59 142.94 55.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.217 0.607 . . . . 0.0 110.45 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 57.0 p -138.76 178.7 6.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.097 0.959 . . . . 0.0 109.519 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -53.0 -30.2 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.026 1.33 . . . . 0.0 112.118 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.47 -23.01 56.62 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.623 1.169 . . . . 0.0 111.97 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -113.94 37.85 3.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.32 1.048 . . . . 0.0 111.147 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 56.2 mt -114.94 102.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 155.21 -161.89 30.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.97 91.6 8.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.617 0.767 . . . . 0.0 109.458 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.48 155.36 33.88 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 22.6 m -147.89 111.46 5.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 59.4 m -77.13 130.87 37.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 170.595 -55.244 -160.865 -76.336 103.166 2.047 103.742 -164.392 65.026 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -131.64 142.44 49.85 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.171 0.989 . . . . 0.0 110.233 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.69 106.61 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.254 1.022 . . . . 0.0 109.368 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.5 m -89.85 87.32 6.91 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.52 -93.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.953 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.42 64.89 8.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.677 0.671 . . . . 0.0 109.377 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.42 41.45 63.34 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.405 1.002 . . . . 0.0 112.056 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -150.08 117.29 6.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.59 99.3 1.27 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.331 0.653 . . . . 0.0 109.696 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -89.65 133.73 34.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -150.59 162.81 39.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.997 0.362 . . . . 0.0 111.905 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.2 t -153.54 139.52 18.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.845 0.858 . . . . 0.0 109.87 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -108.45 145.29 34.87 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.084 1.354 . . . . 0.0 112.123 -169.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.94 106.93 4.68 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.237 1.415 . . . . 0.0 108.685 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.6 tt -87.35 108.45 18.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.1 p -89.53 93.31 9.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.161 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.65 117.78 28.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 108.546 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.44 128.94 37.89 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -77.73 65.98 3.32 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 55.1 p -0.47 -88.27 0.0 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 130.022 3.329 . . . . 0.0 114.872 -169.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.41 82.78 6.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.547 1.139 . . . . 0.0 109.006 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.1 m -76.66 74.79 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.694 0.798 . . . . 0.0 109.947 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 1.044 HD12 ' OXT' ' A' ' 229' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.733 -1.603 . . . . 0.0 110.921 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.573 ' OG ' HG22 ' A' ' 131' ' ' THR . 40.2 t . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.386 0.136 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.37 -36.34 75.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.404 0.681 . . . . 0.0 111.334 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.573 HG22 ' OG ' ' A' ' 129' ' ' SER . 11.9 t -82.91 -47.37 11.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.694 1.197 . . . . 0.0 110.996 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.88 -80.78 0.51 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -157.74 126.43 2.98 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.5 -42.81 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.966 2.444 . . . . 0.0 111.333 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -67.65 133.46 49.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.907 0.883 . . . . 0.0 111.548 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.67 -52.48 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -106.52 124.99 50.43 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.74 1.216 . . . . 0.0 108.468 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttt -157.39 147.37 20.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 109.055 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -168.78 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.527 1.131 . . . . 0.0 112.011 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 t -122.92 -65.18 1.12 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.064 0.946 . . . . 0.0 108.729 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.57 -53.27 0.72 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.939 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.65 121.03 83.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.51 142.95 69.55 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.441 2.76 . . . . 0.0 112.275 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.59 117.96 11.0 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.85 97.17 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -89.76 113.25 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -78.79 92.34 4.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.5 ptm -95.89 179.84 4.96 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.311 1.044 . . . . 0.0 111.896 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.6 m -150.06 135.81 18.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.722 1.609 . . . . 0.0 107.328 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.93 163.1 20.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 110.548 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.82 -49.69 4.06 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -89.07 179.61 6.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.333 1.053 . . . . 0.0 110.755 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -72.98 141.9 47.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.249 0.619 . . . . 0.0 111.032 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.7 tp -132.76 114.16 13.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.834 1.654 . . . . 0.0 107.599 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.0 t -98.8 133.25 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.04 97.35 15.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.63 82.16 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.409 2.739 . . . . 0.0 111.33 -167.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.5 p -127.7 50.63 2.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.032 1.333 . . . . 0.0 109.286 175.168 65.026 -164.392 -76.336 103.742 2.047 103.166 -160.865 -55.244 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.9 ptt180 -70.04 158.22 36.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.244 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.14 168.64 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.315 1.446 . . . . 0.0 110.027 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.2 p -66.11 -26.24 67.37 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.81 0.844 . . . . 0.0 112.983 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.0 m -156.23 146.07 15.56 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.134 0.879 . . . . 0.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.56 -31.6 60.09 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.802 3.001 . . . . 0.0 112.121 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -50.4 -35.25 27.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.423 1.489 . . . . 0.0 112.065 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.36 -41.67 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 110.738 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.5 m 66.46 94.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.467 1.507 . . . . 0.0 111.524 173.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.48 145.43 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.2 m -111.86 125.68 54.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.428 1.091 . . . . 0.0 108.121 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.7 tp -89.39 100.7 13.44 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -91.45 172.38 8.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.89 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -149.36 146.44 27.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.319 1.048 . . . . 0.0 108.444 171.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.92 135.14 83.56 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 110.662 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.6 -58.93 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.728 0 CA-C-N 119.814 0.969 . . . . 0.0 111.839 0.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.85 39.66 1.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.787 1.235 . . . . 0.0 109.631 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -80.56 156.45 26.47 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -127.16 113.23 16.1 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.122 0.969 . . . . 0.0 109.163 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.0 mp -89.86 82.65 6.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.17 129.18 88.39 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.089 0.955 . . . . 0.0 109.292 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.56 84.42 1.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.089 2.526 . . . . 0.0 109.917 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.52 -21.01 61.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.311 1.444 . . . . 0.0 113.367 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.57 29.07 62.19 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.436 0.541 . . . . 0.0 112.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.63 -62.45 0.52 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.829 1.252 . . . . 0.0 108.297 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -87.46 -60.86 1.86 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 36.1 mt -89.67 93.23 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.1 mt -96.72 119.22 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 108.121 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -89.13 96.88 10.9 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.219 0.607 . . . . 0.0 109.6 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -92.36 101.02 13.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 172.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.703 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 76.9 p -54.15 -31.42 52.44 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.634 0.774 . . . . 0.0 113.07 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -100.72 19.64 16.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.365 1.066 . . . . 0.0 112.336 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -147.58 -55.13 0.22 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.846 0.748 . . . . 0.0 111.298 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.46 -170.55 35.75 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -88.93 107.67 19.14 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 52.7 mt -89.88 94.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.598 1.559 . . . . 0.0 107.961 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.48 94.5 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.5 p -58.33 -39.79 80.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.773 1.229 . . . . 0.0 112.484 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -118.46 96.81 5.46 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.739 1.215 . . . . 0.0 107.98 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.59 142.94 55.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.217 0.607 . . . . 0.0 110.45 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 57.0 p -138.76 178.7 6.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.097 0.959 . . . . 0.0 109.519 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -53.0 -30.2 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.026 1.33 . . . . 0.0 112.118 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.47 -23.01 56.62 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.623 1.169 . . . . 0.0 111.97 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -113.94 37.85 3.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.32 1.048 . . . . 0.0 111.147 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 56.2 mt -114.94 102.81 14.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 155.21 -161.89 30.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.97 91.6 8.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.617 0.767 . . . . 0.0 109.458 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.48 155.36 33.88 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 22.6 m -147.89 111.46 5.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 59.4 m -77.13 130.87 37.92 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 170.595 -55.244 -160.865 -76.336 103.166 2.047 103.742 -164.392 65.026 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -131.64 142.44 49.85 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.171 0.989 . . . . 0.0 110.233 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.69 106.61 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.254 1.022 . . . . 0.0 109.368 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.5 m -89.85 87.32 6.91 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.4 t -84.52 -93.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.953 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.42 64.89 8.91 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.677 0.671 . . . . 0.0 109.377 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.42 41.45 63.34 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.405 1.002 . . . . 0.0 112.056 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -150.08 117.29 6.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.59 99.3 1.27 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.331 0.653 . . . . 0.0 109.696 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -89.65 133.73 34.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -150.59 162.81 39.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.997 0.362 . . . . 0.0 111.905 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.2 t -153.54 139.52 18.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.845 0.858 . . . . 0.0 109.87 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -108.45 145.29 34.87 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.084 1.354 . . . . 0.0 112.123 -169.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.94 106.93 4.68 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.237 1.415 . . . . 0.0 108.685 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.6 tt -87.35 108.45 18.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.1 p -89.53 93.31 9.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.161 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.65 117.78 28.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 108.546 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.44 128.94 37.89 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -77.73 65.98 3.32 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 55.1 p -0.47 -88.27 0.0 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 130.022 3.329 . . . . 0.0 114.872 -169.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.41 82.78 6.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.547 1.139 . . . . 0.0 109.006 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.1 m -76.66 74.79 3.34 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.694 0.798 . . . . 0.0 109.947 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 1.044 ' OXT' HD12 ' A' ' 229' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.733 -1.603 . . . . 0.0 110.921 178.031 . . . . . . . . 2 2 . 1 stop_ save_